Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1984 Jan;81(1):31–39. doi: 10.1111/j.1476-5381.1984.tb10740.x

In vivo platelet aggregation in the rat: dependence on extracellular divalent cation and inhibition by nonsteroidal anti-inflammatory drugs.

G Mallarkey, G M Smith
PMCID: PMC1986969  PMID: 6423018

Abstract

Using the Technicon Autocounter, the mechanisms involved in collagen-induced platelet aggregation in vivo have been studied without the interference of an anticoagulant. Extracellular divalent cation was essential for in vivo platelet aggregation. Non-steroidal anti-inflammatory drugs completely inhibited the aggregation induced by collagen in platelet-rich plasma in in vitro or ex vivo studies. In vivo only a maximum of 50% inhibition was achieved when release of thromboxane A2 (TXA2) was completely inhibited. Therefore in vivo, collagen causes aggregation through more than one pathway which operate independently of each other and which are all dependent on extracellular divalent cation. In vivo, when different doses of collagen were compared, aggregation produced by low doses of collagen was more dependent upon prostaglandin endoperoxide/TXA2 formation.

Full text

PDF
31

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ali M., McDonald J. W. Effects of sulfinpyrazone on platelet prostaglandin synthesis and platelet release of serotonin. J Lab Clin Med. 1977 Apr;89(4):868–875. [PubMed] [Google Scholar]
  2. Ali M., McDonald J. W. Reversible and irreversible inhibition of platelet cyclooxygenase and serotonin release by nonsteroidal antinflammatory drugs. Thromb Res. 1978 Dec;13(6):1057–1065. doi: 10.1016/0049-3848(78)90234-7. [DOI] [PubMed] [Google Scholar]
  3. Aursnes I., Gjesdal K., Abildgaard U. Platelet aggregation induced by ADP from unsheared erythrocytes at physiological Ca++-concentration. Br J Haematol. 1981 Jan;47(1):149–152. doi: 10.1111/j.1365-2141.1981.tb02769.x. [DOI] [PubMed] [Google Scholar]
  4. BORN G. V., CROSS M. J. THE AGGREGATION OF BLOOD PLATELETS. J Physiol. 1963 Aug;168:178–195. doi: 10.1113/jphysiol.1963.sp007185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Best L. C., Holland T. K., Jones P. B., Russell R. G. The interrelationship between thromboxane biosynthesis, aggregation and 5-hydroxytryptamine secretion in human platelets in vitro. Thromb Haemost. 1980 Feb 29;43(1):38–40. [PubMed] [Google Scholar]
  6. Born G. V., Wehmeier A. Inhibition of platelet thrombus formation by chlorpromazine acting to diminish haemolysis. Nature. 1979 Nov 8;282(5735):212–213. doi: 10.1038/282212a0. [DOI] [PubMed] [Google Scholar]
  7. Botney M., Swanson A. L., Shuman M. Thrombin-induced and collagen-induced platelet aggregation. Thromb Haemost. 1980 Feb 29;42(5):1684–1685. [PubMed] [Google Scholar]
  8. Buchanan M. R., Rosenfeld J., Hirsh J. The prolonged effect of sulfinpyrazone on collagen-induced platelet aggregation in vivo. Thromb Res. 1978 Nov;13(5):883–892. doi: 10.1016/0049-3848(78)90193-7. [DOI] [PubMed] [Google Scholar]
  9. Buchanan M., Hirsh J. Proceedings: Comparison of in vivo and in vitro effects of platelet function suppressing drugs. Thromb Diath Haemorrh. 1975 Nov 15;34(2):552–552. [PubMed] [Google Scholar]
  10. Bunting S., Gryglewski R., Moncada S., Vane J. R. Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac ateries and inhibits platelet aggregation. Prostaglandins. 1976 Dec;12(6):897–913. doi: 10.1016/0090-6980(76)90125-8. [DOI] [PubMed] [Google Scholar]
  11. Carty T. J., Stevens J. S., Lombardino J. G., Parry M. J., Randall M. J. Piroxicam, a structurally novel anti-inflammatory compound. Mode of prostaglandin synthesis inhibition. Prostaglandins. 1980 May;19(5):671–682. doi: 10.1016/0090-6980(80)90166-5. [DOI] [PubMed] [Google Scholar]
  12. Cazenave J. P., Packham M. A., Mustard J. F. Adherence of platelets to a collagen-coated surface: development of a quantitative method. J Lab Clin Med. 1973 Dec;82(6):978–990. [PubMed] [Google Scholar]
  13. Charo I. F., Feinman R. D., Detwiler T. C., Smith J. B., Ingerman C. M., Silver M. J. Prostaglandin endoperoxides and thromboxane A2 can induce platelet aggregation in the absence of secretion. Nature. 1977 Sep 1;269(5623):66–69. doi: 10.1038/269066a0. [DOI] [PubMed] [Google Scholar]
  14. Dutilh C. E., Haddeman E., Don J. A., ten Hoor F. The role of arachidonate lipoxygenase and fatty acids during irreversible blood platelet aggregation in vitro. Prostaglandins Med. 1981 Feb;6(2):111–126. doi: 10.1016/0161-4630(81)90081-1. [DOI] [PubMed] [Google Scholar]
  15. Gryglewski R. J., Bunting S., Moncada S., Flower R. J., Vane J. R. Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides. Prostaglandins. 1976 Nov;12(5):685–713. doi: 10.1016/0090-6980(76)90047-2. [DOI] [PubMed] [Google Scholar]
  16. Heptinstall S., Taylor P. M. The effects of citrate and extracellular calcium ions on the platelet release reaction induced by adenosine diphosphate and collagen. Thromb Haemost. 1979 Aug 31;42(2):778–793. [PubMed] [Google Scholar]
  17. Huzoor-Akbar, Ardlie N. G. Investigation of the role of arachidonic acid in platelet function and mechanisms for suppression of prostaglandin biosynthesis. Br J Haematol. 1978 May;39(1):71–81. doi: 10.1111/j.1365-2141.1978.tb07129.x. [DOI] [PubMed] [Google Scholar]
  18. Kinlough-Rathbone R. L., Cazenave J. P., Packham M. A., Mustard J. F. Effect of inhibitors of the arachidonate pathway on the release of granule contents from rabbit platelets adherent to collagen. Lab Invest. 1980 Jan;42(1):28–34. [PubMed] [Google Scholar]
  19. Kinlough-Rathbone R. L., Packham M. A., Mustard J. F. Synergism between platelet aggregating agents: the role of the arachidonate pathway. Thromb Res. 1977 Nov;11(5):567–580. doi: 10.1016/0049-3848(77)90016-0. [DOI] [PubMed] [Google Scholar]
  20. Kinlough-Rathbone R. L., Reimers H. J., Mustard J. F., Packham M. A. Sodium arachidonate can induce platelet shape change and aggregation which are independent of the release reaction. Science. 1976 Jun 4;192(4243):1011–1012. doi: 10.1126/science.1273582. [DOI] [PubMed] [Google Scholar]
  21. Lages B., Weiss H. J. Dependence of human platelet functional responses on divalent cations: aggregation and secretion in heparin- and hirudin-anticoagulated platelet-rich plasma and the effects of chelating agents. Thromb Haemost. 1981 Apr 30;45(2):173–179. [PubMed] [Google Scholar]
  22. Malmsten C., Hamberg M., Svensson J., Samuelsson B. Physiological role of an endoperoxide in human platelets: hemostatic defect due to platelet cyclo-oxygenase deficiency. Proc Natl Acad Sci U S A. 1975 Apr;72(4):1446–1450. doi: 10.1073/pnas.72.4.1446. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Mustard J. F., Perry D. W., Kinlough-Rathbone R. L., Packham M. A. Factors responsible for ADP-induced release reaction of human platelets. Am J Physiol. 1975 Jun;228(6):1757–1765. doi: 10.1152/ajplegacy.1975.228.6.1757. [DOI] [PubMed] [Google Scholar]
  24. Needleman P., Wyche A., Raz A. Platelet and blood vessel arachidonate metabolism and interactions. J Clin Invest. 1979 Feb;63(2):345–349. doi: 10.1172/JCI109309. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Northover B. J. Indomethacin--a calcium antagonist. Gen Pharmacol. 1977;8(5-6):293–296. doi: 10.1016/0306-3623(77)90001-5. [DOI] [PubMed] [Google Scholar]
  26. Packham M. A., Guccione M. A., Greenberg J. P., Kinlough-Rathbone R. L., Mustard J. F. Release of 14C-serotonin during initial platelet changes induced by thrombin, collagen, or A23187. Blood. 1977 Nov;50(5):915–926. [PubMed] [Google Scholar]
  27. Page C. P., Paul W., Morley J. An in vivo model for studying platelet aggregation and disaggregation. Thromb Haemost. 1982 Jun 28;47(3):210–213. [PubMed] [Google Scholar]
  28. Parise L. V., Venton D. L., Le Breton G. C. Thromboxane A2/prostaglandin H2 directly stimulates platelet shape change independent of secreted ADP. J Pharmacol Exp Ther. 1982 Jul;222(1):276–281. [PubMed] [Google Scholar]
  29. Pay G. F., Wallis R. B., Zelaschi D. The effect of sulphinpyrazone and its metabolites on platelet function in vitro and ex vivo. Haemostasis. 1981;10(3):165–175. doi: 10.1159/000214400. [DOI] [PubMed] [Google Scholar]
  30. Rodbard D., Bridson W., Rayford P. L. Rapid calculation of radioimmunoassay results. J Lab Clin Med. 1969 Nov;74(5):770–781. [PubMed] [Google Scholar]
  31. Samuelsson B. Prostaglandin endoperoxides and thromboxanes: role in platelets and in vascular and respiratory smooth muscle. Acta Biol Med Ger. 1976;35(8-9):1055–1063. [PubMed] [Google Scholar]
  32. Scrutton M. C., Egan C. M. Divalent cation requirements for aggregation of human blood platelets and the role of the anti-coagulant. Thromb Res. 1979;14(4-5):713–727. doi: 10.1016/0049-3848(79)90127-0. [DOI] [PubMed] [Google Scholar]
  33. Seuter F. Inhibition of platelet aggregation by acetylsalicylic acid and other inhibitors. Haemostasis. 1976;5(2):85–95. doi: 10.1159/000214122. [DOI] [PubMed] [Google Scholar]
  34. Siegel M. I., McConnell R. T., Cuatrecasas P. Aspirin-like drugs interfere with arachidonate metabolism by inhibition of the 12-hydroperoxy-5,8,10,14-eicosatetraenoic acid peroxidase activity of the lipoxygenase pathway. Proc Natl Acad Sci U S A. 1979 Aug;76(8):3774–3778. doi: 10.1073/pnas.76.8.3774. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Smith G. M., Freuler F. The measurement of intravascular aggregation by continuous platelet counting. Bibl Anat. 1973;12:229–234. [PubMed] [Google Scholar]
  36. Vargaftig B. B., Chignard M., Benveniste J., Lefort J., Wal F. Background and present status of research on platelet-activating factor (PAF-acether). Ann N Y Acad Sci. 1981;370:119–137. doi: 10.1111/j.1749-6632.1981.tb29727.x. [DOI] [PubMed] [Google Scholar]
  37. Vargaftig B. B., Chignard M., Benveniste J. Present concepts on the mechanisms of platelet aggregation. Biochem Pharmacol. 1981 Feb 15;30(4):263–271. doi: 10.1016/0006-2952(81)90052-6. [DOI] [PubMed] [Google Scholar]
  38. Wiley J. S., Chesterman C. N., Morgan F. J., Castaldi P. A. The effect of sulphinpyrazone on the aggregation and release reactions of human platelets. Thromb Res. 1979 Jan;14(1):23–33. doi: 10.1016/0049-3848(79)90021-5. [DOI] [PubMed] [Google Scholar]
  39. Zucker M. B., Peterson J. Effect of acetylsalicylic acid, other nonsteroidal anti-inflammatory agents, and dipyridamole on human blood platelets. J Lab Clin Med. 1970 Jul;76(1):66–75. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES